by GlaxoSmithKline
Retrovir I.V. Infusion is supplied by GlaxoSmithKline under product code RETROVIR IV INFUSION 10 MG/ML, RETROVIR INJECTION 10 MG/ML, RETROVIR/AZT INJECTION 10 MG/ML, RETROVIR/AZT INFUSIEVLOEISTOF 10 MG/ML, RETROVIR I.V, RETROVIR I.V FOR INFUSION, RETROVIR I.V PARA INFUS ION, RETROVIR I.V SOLUCAO PARA PERFUSAO INTRAVENOSA, RETROVIR INFUSION, RETROVIR INFUSIONSKONCENTRAT, RETROVIR INIETTABILE, RETROVIR INYECTABLE, RETROVIR IV PRO INFUZE, RETROVIR MIKSTUR, RETROVIR SOLUTIO N INJECTABLE, RETROVIR ZAWIESINA DO INIEKCJI, ZIDOVUDINE, FORMULATED PROD UCT. This page provides both the Safety Data Sheet (SDS) and the Chemical Risk Assessment (CRA) for this substance, under GHS/CLP regulations for UK workplace use under COSHH. The full SDS and CRA documents are available to download above.
This SDS was last revised on 24 May 2018. The matching CRA is updated in line with SDS revisions. Workplaces handling this substance should retain a current SDS and risk assessment for the duration of use.
Switch between the Safety Data Sheet and the Chemical Risk Assessment for this substance.
Need the full hazard breakdown? Precautionary statements, first aid, physical properties and exposure controls are in the full SDS PDF.
Need to download the Chemical Risk Assessment? The full CRA PDF includes all hazard classifications, regulatory statements and recommended controls.